| scholarly article | Q13442814 |
| P2093 | author name string | F Ahmadi | |
| A Mahdizadeh | |||
| M Mahdavi-Mazdeh | |||
| M R Khatami | |||
| S Dashti-Khavidaki | |||
| M T Najafi | |||
| M Gatmiri | |||
| S Derafshi | |||
| Z Foroozanfar | |||
| P2860 | cites work | Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 |
| Rituximab for humoral rejection after kidney transplantation: an update | Q47966531 | ||
| A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient. | Q52939658 | ||
| One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation | Q56907959 | ||
| Pharmacodynamics of Rituximab in Kidney Allotransplantation | Q62588643 | ||
| Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation | Q77736829 | ||
| Rituximab therapy for acute humoral rejection after kidney transplantation | Q80318231 | ||
| Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report | Q80664944 | ||
| Treatment of antibody-mediated rejection after kidney transplantation | Q81548947 | ||
| A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation | Q82026577 | ||
| Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment | Q34977911 | ||
| Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols | Q35849009 | ||
| Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease. | Q37369319 | ||
| Antibody-mediated rejection in kidney transplantation: an update | Q37835834 | ||
| Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options | Q38206175 | ||
| Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection. | Q39716270 | ||
| Rituximab-Related Late-Onset Neutropenia in Kidney Transplant Recipients Treated for Antibody-Mediated Acute Rejection. | Q40475143 | ||
| A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody | Q41703314 | ||
| Acute antibody-mediated rejection in pediatric kidney transplants: a single center experience | Q42280145 | ||
| Treatment of Acute Antibody-Mediated Rejection: A Single-Center Experience | Q42849688 | ||
| Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation | Q43241188 | ||
| High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis | Q43906723 | ||
| A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection | Q44197767 | ||
| Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection | Q44469234 | ||
| Low- versus high-dose rituximab for antibody-mediated rejection after kidney transplantation | Q44722151 | ||
| Rituximab as treatment for refractory kidney transplant rejection | Q44899030 | ||
| Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection | Q45061984 | ||
| Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab | Q45230226 | ||
| Impact of rituximab therapy for treatment of acute humoral rejection | Q45361905 | ||
| Diagnosis and treatment of acute humoral kidney allograft rejection. | Q46045914 | ||
| Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant | Q46293120 | ||
| Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report | Q46843837 | ||
| Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. | Q47862854 | ||
| P433 | issue | 3 | |
| P921 | main subject | rituximab | Q412323 |
| P304 | page(s) | 127-136 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | International journal of organ transplantation medicine | Q26853977 |
| P1476 | title | Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients | |
| P478 | volume | 10 |
Search more.